VNRX

VOLITIONRX LTD

NYSE· In Vitro & In Vivo Diagnostic Substances· Inc. DE· CIK 0000093314 Biotech & Drug Discovery

$0.1800 +0.01 (+5.88%)

Oct 26 4:00 PM ET · prev $0.1700

Market cap

$5.1M

Nano cap

Median target

$20.00

+11011% · range $2.00–24.00

Next earnings

Nov 12

in 16 days · EPS est. −$0.31

1 year

−98.0%

from $8.80 · Oct 27

30 days

−28.0%

from $0.2500

52-week range

$0.1700–9.00

−98% from high · low Oct 19

Avg volume 20D

1.41M

Oct 1 spike 8.13M

Short interest

🔒 Subscribers only

Insider net

no open-market trades · 12 mo

Filing reports

analyzed by SecBot

SecBot read BEARISH 8 reports · 90 days

Balance 7 bearish · 0 bullish · 1 neutral oldest → newest, height = score

Avg score

·High conf. 7/8 ·Next Earnings date, Nov 12, 2026

Strongest BEARISH VolitionRx issued 2,157,340 shares to Lind Global Asset Management XII LLC via two debt conversions totaling…

All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

A Apr 20 D. Boral Capital downgrades
R Apr 23 VolitionRx received NYSE American's acceptance of its plan to regain…
X Aug 31 Short interest jumps 225.2% to 2.22M
R Sep 1 VolitionRx issued 4,698,628 shares to Lind Global Asset Management X…
R Sep 9 VolitionRx filed Pre-Effective Amendment No. 2 to its S-3 shelf regi…
R Sep 11 VolitionRx's S-3 shelf registration (File No. 333-298627) became eff…
X Sep 15 Short interest falls 54.8% to 1.00M
R Sep 25 VolitionRx issued 2,157,340 shares to Lind Global Asset Management X…

Signal stack

Where each data set points today.

InsidersNO TRADES

No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.
EstimatesRISING

Current-quarter EPS estimate −$0.700 → −$0.310 over 90 days.
TrendDOWNTREND

38% below its 50-day average. New closing low $0.1700 on Oct 23.

Who's buying

13F

Top holder	Shares	Value
GEODE CAPITAL MANAGEMENT, LLC	55,537	$75.0K
VANGUARD CAPITAL MANAGEMENT LLC	50,684	$68.4K
Wealthspire Advisors, LLC	45,000	$60.8K
STATE STREET CORP	33,995	$45.9K
VANGUARD FIDUCIARY TRUST CO	25,133	$33.9K
BlackRock, Inc.	22,308	$30.1K
NORTHERN TRUST CORP	12,978	$17.5K
Squarepoint Ops LLC	10,685	$14.4K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action Apr 2026

12-month targets · 5 analysts

$0.1800 $2.00 $20.00 $24.00

Price is below the lowest target. Median implies +11011%.Targets as of Oct 27, 2026.

Recent actions

Date	Firm	Action	Rating
Apr 20, 2026	D. Boral Capital DOWNGRADE	DOWNGRADE	Hold
Apr 2, 2026	HC Wainwright & Co. MAINTAIN	MAINTAIN	Buy
Mar 31, 2026	D. Boral Capital MAINTAIN	MAINTAIN	Buy
Mar 26, 2026	D. Boral Capital MAINTAIN	MAINTAIN	Buy
Mar 18, 2026	D. Boral Capital MAINTAIN	MAINTAIN	Buy
Jan 21, 2026	D. Boral Capital MAINTAIN	MAINTAIN	Buy

Insider ledger

Form 4

🔒 Subscribers only

3 transactions

Date	Insider	Type
Oct 21, 2026	🔒 Fresh data, subscribers only	AWARD
Sep 28, 2026	🔒 Fresh data, subscribers only	TAX W/H
Sep 28, 2026	🔒 Fresh data, subscribers only	TAX W/H

Earnings setup

Estimates

Nov 12

reports in 16 days

−$0.31

EPS estimate, this quarter

+56%

estimate change, 90 days

Current-quarter EPS estimate

−$0.700

90d

−$0.580

60d

−$0.580

30d

−$0.580

−$0.310

Now

Period	EPS est.	Range	30D rev.	Revenue
Current Q	-$0.31	-$0.31–-$0.31	+46.6%	$696.1K
Next Q	-$0.29	-$0.29–-$0.29	+40.8%	$710.0K
Current FY	-$2.00	-$2.00–-$2.00	+23.7%	$2.7M
Next FY	-$0.85	-$0.85–-$0.85	+26.1%	$9.3M